help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masuyama, H.
Right arrow Articles by MacDonald, P. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masuyama, H.
Right arrow Articles by MacDonald, P. N.
Molecular Endocrinology 11 (2): 218-228
Copyright © 1997 by The Endocrine Society

The N-Terminal Domain of Transcription Factor IIB Is Required for Direct Interaction with the Vitamin D Receptor and Participates in Vitamin D-Mediated Transcription

Hisashi Masuyama, Stephen C. Jefcoat, Jr. and Paul N. MacDonald

St. Louis University Health Sciences Center Department of Pharmacological and Physiological Science St. Louis, Missouri 63104

The interaction of the vitamin D receptor (VDR) with transcription factor IIB (TFIIB) represents a potential physical link between the VDR-DNA complex and the transcription preinitiation complex. However, the functional relevance of the VDR-TFIIB interaction in vitamin D-mediated transcription is not well understood. In the present study, we used site-directed mutagenesis to demonstrate that the structural integrity of the amino-terminal zinc finger of TFIIB is essential for VDR-TFIIB complex formation. Altering the putative zinc-coordinating residues (C15, C34, C37, or H18) to serines abolished TFIIB interaction with the VDR as assessed in a yeast two-hybrid system and by in vitro protein interaction assays. This N-terminal, VDR-interactive domain functioned as a selective, dominant-negative inhibitor of vitamin D-mediated transcription. Expressing amino acids 1–124 of human TFIIB (N-TFIIB) in COS-7 cells or in osteoblastic ROS17/2.8 cells effectively suppressed 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3)-induced transcription, but had no effect on basal or glucocorticoid-activated transcription. A mutant N-terminal domain [N-TFIIB(C34S:C37S)] that does not interact with VDR had no impact on 1,25-(OH)2D3-induced transcription. Interestingly, both in vitro and in vivo protein interaction assays showed that the VDR-TFIIB protein complex was disrupted by the 1,25-(OH)2D3 ligand. Mechanistically, these data establish a functional role for the N terminus of TFIIB in VDR-mediated transcription, and they allude to a role for unliganded VDR in targeting TFIIB to the promoter regions of vitamin D-responsive target genes.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J. Dong, C.-H. Tsai-Morris, and M. L. Dufau
A Novel Estradiol/Estrogen Receptor {alpha}-dependent Transcriptional Mechanism Controls Expression of the Human Prolactin Receptor
J. Biol. Chem., July 7, 2006; 281(27): 18825 - 18836.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. L. M. Sutton, X. Zhang, T. I. Ellison, and P. N. MacDonald
The 1,25(OH)2D3-Regulated Transcription Factor MN1 Stimulates Vitamin D Receptor-Mediated Transcription and Inhibits Osteoblastic Cell Proliferation
Mol. Endocrinol., September 1, 2005; 19(9): 2234 - 2244.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T. I. Ellison, D. R. Dowd, and P. N. MacDonald
Calmodulin-Dependent Kinase IV Stimulates Vitamin D Receptor-Mediated Transcription
Mol. Endocrinol., September 1, 2005; 19(9): 2309 - 2319.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. L. M. Sutton and P. N. MacDonald
Vitamin D: More Than a "Bone-a-Fide" Hormone
Mol. Endocrinol., May 1, 2003; 17(5): 777 - 791.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. B. Barry, G. M. Leong, W. B. Church, L. L. Issa, J. A. Eisman, and E. M. Gardiner
Interactions of SKIP/NCoA-62, TFIIB, and Retinoid X Receptor with Vitamin D Receptor Helix H10 Residues
J. Biol. Chem., February 28, 2003; 278(10): 8224 - 8228.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Masuyama, H. Inoshita, Y. Hiramatsu, and T. Kudo
Ligands Have Various Potential Effects on the Degradation of Pregnane X Receptor by Proteasome
Endocrinology, January 1, 2002; 143(1): 55 - 61.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
A. Aranda and A. Pascual
Nuclear Hormone Receptors and Gene Expression
Physiol Rev, July 1, 2001; 81(3): 1269 - 1304.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. Raval-Pandya, P. Dhawan, F. Barletta, and S. Christakos
YY1 Represses Vitamin D Receptor-Mediated 25-Hydroxyvitamin D3 24-Hydroxylase Transcription: Relief of Repression by CREB-Binding Protein
Mol. Endocrinol., June 1, 2001; 15(6): 1035 - 1046.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Tocchini-Valentini, N. Rochel, J. M. Wurtz, A. Mitschler, and D. Moras
Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands
PNAS, May 8, 2001; 98(10): 5491 - 5496.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
S. Hahn and S. Roberts
The zinc ribbon domains of the general transcription factors TFIIB and Brf: conserved functional surfaces but different roles in transcription initiation
Genes & Dev., March 15, 2000; 14(6): 719 - 730.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
P. W. Jurutka, L. S. Remus, G. K. Whitfield, P. D. Thompson, J.-C. Hsieh, H. Zitzer, P. Tavakkoli, M. A. Galligan, H. T. L. Dang, C. A. Haussler, et al.
The Polymorphic N Terminus in Human Vitamin D Receptor Isoforms Influences Transcriptional Activity by Modulating Interaction with Transcription Factor IIB
Mol. Endocrinol., March 1, 2000; 14(3): 401 - 420.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
H. Masuyama, Y. Hiramatsu, M. Kunitomi, T. Kudo, and P. N. MacDonald
Endocrine Disrupting Chemicals, Phthalic Acid and Nonylphenol, Activate Pregnane X Receptor-Mediated Transcription
Mol. Endocrinol., March 1, 2000; 14(3): 421 - 428.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
L.-A. Li, E. F-L. Chiang, J.-C. Chen, N.-C. Hsu, Y.-J. Chen, and B.-c. Chung
Function of Steroidogenic Factor 1 Domains in Nuclear Localization, Transactivation, and Interaction with Transcription Factor TFIIB and c-Jun
Mol. Endocrinol., September 1, 1999; 13(9): 1588 - 1598.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. J. Brown, A. Dusso, and E. Slatopolsky
Vitamin D
Am J Physiol Renal Physiol, August 1, 1999; 277(2): F157 - F175.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Racz and J. Barsony
Hormone-dependent Translocation of Vitamin D Receptors Is Linked to Transactivation
J. Biol. Chem., July 2, 1999; 274(27): 19352 - 19360.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. M. Jiménez-Lara and A. Aranda
Vitamin D Represses Retinoic Acid-Dependent Transactivation of the Retinoic Acid Receptor-{beta}2 Promoter: The AF-2 Domain of the Vitamin D Receptor Is Required for Transrepression
Endocrinology, June 1, 1999; 140(6): 2898 - 2907.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
D. M. Kraichely, J. J. Collins III, R. K. DeLisle, and P. N. MacDonald
The Autonomous Transactivation Domain in Helix H3 of the Vitamin D Receptor Is Required For Transactivation and Coactivator Interaction
J. Biol. Chem., May 14, 1999; 274(20): 14352 - 14358.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
G. JONES, S. A. STRUGNELL, and H. F. DeLUCA
Current Understanding of the Molecular Actions of Vitamin D
Physiol Rev, October 1, 1998; 78(4): 1193 - 1231.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. Raval-Pandya, L. P. Freedman, H. Li, and S. Christakos
Thyroid Hormone Receptor Does Not Heterodimerize with the Vitamin D Receptor but Represses Vitamin D Receptor-Mediated Transactivation
Mol. Endocrinol., September 1, 1998; 12(9): 1367 - 1379.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
A. J. Bird, J. S. Turner-Cavet, J. H. Lakey, and N. J. Robinson
A Carboxyl-terminal Cys2/His2-type Zinc-finger Motif in DNA Primase Influences DNA Content in Synechococcus PCC 7942
J. Biol. Chem., August 14, 1998; 273(33): 21246 - 21252.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Sela-Brown, J. Russell, N. J. Koszewski, M. Michalak, T. Naveh-Many, and J. Silver
Calreticulin Inhibits Vitamin D's Action on the PTH Gene in Vitro and May Prevent Vitamin D's Effect in Vivo in Hypocalcemic Rats
Mol. Endocrinol., August 1, 1998; 12(8): 1193 - 1200.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
J.-M. Yao, D. E. Breiding, and E. J. Androphy
Functional Interaction of the Bovine Papillomavirus E2 Transactivation Domain with TFIIB
J. Virol., February 1, 1998; 72(2): 1013 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. M. Leong, K. S. Wang, M. J. Marton, J. C. G. Blanco, I-M. Wang, R. J. Rolfes, K. Ozato, and J. H. Segars
Interaction between the Retinoid X Receptor and Transcription Factor IIB Is Ligand-dependent in Vivo
J. Biol. Chem., January 23, 1998; 273(4): 2296 - 2305.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
H. Masuyama, C. M. Brownfield, R. St-Arnaud, and P. N. MacDonald
Evidence for Ligand-Dependent Intramolecular Folding of the AF-2 Domain in Vitamin D Receptor-Activated Transcription and Coactivator Interaction
Mol. Endocrinol., September 1, 1997; 11(10): 1507 - 1517.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society